INTRODUCTION: Recent studies indicate that decreased energy generation by mitochondria is a feature that is common across neurodegenerative diseases. PATIENTS AND METHODS: In order to obtain direct evidence that mitochondrial functioning is altered, we measured the hydrolytic activity of F0F1-ATPase and its capacity to generate a stable proton gradient in submitochondrial particles in 29 patients diagnosed with probable Alzheimer's disease (AD). Submitochondrial particles were obtained from platelets of patients with a diagnosis of probable AD and from clinically healthy controls. RESULTS: Data revealed that the hydrolytic activity of F0F1-ATPase increases significantly in patients with probable AD (41.7+/-4.3 nmol PO4 min-1[mg protein]-1, n=29) as compared to the control subjects (29.1+/-1.9 nmol PO4 min-1 [mg protein]-1, n=29). It is important to note that, in the male population with probable AD, we found that hydrolytic activity of F0F1-ATPase increased as cerebral deterioration progressed. We also detected a lower pH gradient in the submitochondrial particles of patients with probable AD (0.28+/-0.08 pH units, n=25) as compared to the controls (0.5+/-0.1 pH units, n=20). CONCLUSIONS: Overall, these data point to an alteration in the functioning of the enzyme.
INTRODUCTION: Recent studies indicate that decreased energy generation by mitochondria is a feature that is common across neurodegenerative diseases. PATIENTS AND METHODS: In order to obtain direct evidence that mitochondrial functioning is altered, we measured the hydrolytic activity of F0F1-ATPase and its capacity to generate a stable proton gradient in submitochondrial particles in 29 patients diagnosed with probable Alzheimer's disease (AD). Submitochondrial particles were obtained from platelets of patients with a diagnosis of probable AD and from clinically healthy controls. RESULTS: Data revealed that the hydrolytic activity of F0F1-ATPase increases significantly in patients with probable AD (41.7+/-4.3 nmol PO4min-1[mg protein]-1, n=29) as compared to the control subjects (29.1+/-1.9 nmol PO4min-1 [mg protein]-1, n=29). It is important to note that, in the male population with probable AD, we found that hydrolytic activity of F0F1-ATPase increased as cerebral deterioration progressed. We also detected a lower pH gradient in the submitochondrial particles of patients with probable AD (0.28+/-0.08 pH units, n=25) as compared to the controls (0.5+/-0.1 pH units, n=20). CONCLUSIONS: Overall, these data point to an alteration in the functioning of the enzyme.
Authors: Margarita Cid-Hernández; Ana C Ramírez-Anguiano; Genaro G Ortiz; Eddic W Morales-Sánchez; Luis J González-Ortiz; Sandra F Velasco-Ramírez; Fermín P Pacheco-Moisés Journal: Biol Res Date: 2015-03-19 Impact factor: 5.612
Authors: Simon J Beck; Lan Guo; Aarron Phensy; Jing Tian; Lu Wang; Neha Tandon; Esha Gauba; Lin Lu; Juan M Pascual; Sven Kroener; Heng Du Journal: Nat Commun Date: 2016-05-06 Impact factor: 14.919
Authors: Adolfo Daniel Rodríguez-Carrizalez; José Alberto Castellanos-González; Esaú César Martínez-Romero; Guillermo Miller-Arrevillaga; David Villa-Hernández; Pedro Pablo Hernández-Godínez; Genaro Gabriel Ortiz; Fermín Paul Pacheco-Moisés; Ernesto Germán Cardona-Muñoz; Alejandra Guillermina Miranda-Díaz Journal: J Diabetes Date: 2013-08-21 Impact factor: 4.006
Authors: Adolfo Daniel Rodríguez-Carrizalez; José Alberto Castellanos-González; Esaú César Martínez-Romero; Guillermo Miller-Arrevillaga; Luis Miguel Román-Pintos; Fermín Paul Pacheco-Moisés; Alejandra Guillermina Miranda-Díaz Journal: Redox Rep Date: 2016-02-05 Impact factor: 4.412